Qingdao Vland Biotech Co Ltd (603739) — Net Asset Quality Index
Qingdao Vland Biotech Co Ltd (603739) has a Net Asset Quality Index of 62.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.04 Billion minus total liabilities of CN¥1.14 Billion yields net assets of CN¥1.90 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of Qingdao Vland Biotech Co Ltd to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Qingdao Vland Biotech Co Ltd Net Asset Quality Index Over Time (2014–2024)
This chart shows how Qingdao Vland Biotech Co Ltd's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 62.5%, representing net assets of CN¥1.90 Billion against total assets of CN¥3.04 Billion CNY. See how liquid is Qingdao Vland Biotech Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Qingdao Vland Biotech Co Ltd (2014–2024)
The table below presents the year-by-year Net Asset Quality Index for Qingdao Vland Biotech Co Ltd from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Qingdao Vland Biotech Co Ltd market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 62.7% | CN¥1.87 Billion | CN¥2.98 Billion | CN¥1.11 Billion | ▲ +2.6 pp |
| 2023 | 60.2% | CN¥1.83 Billion | CN¥3.03 Billion | CN¥1.21 Billion | ▼ -7.1 pp |
| 2022 | 67.2% | CN¥1.73 Billion | CN¥2.58 Billion | CN¥844.93 Million | ▼ -8.6 pp |
| 2021 | 75.9% | CN¥1.69 Billion | CN¥2.22 Billion | CN¥536.18 Million | ▼ -1.0 pp |
| 2020 | 76.8% | CN¥1.12 Billion | CN¥1.45 Billion | CN¥336.22 Million | ▼ -3.7 pp |
| 2019 | 80.6% | CN¥1.03 Billion | CN¥1.28 Billion | CN¥248.99 Million | ▲ +13.8 pp |
| 2018 | 66.8% | CN¥631.38 Million | CN¥945.32 Million | CN¥313.94 Million | ▼ -0.3 pp |
| 2017 | 67.1% | CN¥592.53 Million | CN¥883.55 Million | CN¥291.02 Million | ▼ -0.3 pp |
| 2016 | 67.4% | CN¥557.97 Million | CN¥827.92 Million | CN¥269.96 Million | ▲ +4.2 pp |
| 2015 | 63.2% | CN¥519.36 Million | CN¥821.63 Million | CN¥302.27 Million | ▲ +4.5 pp |
| 2014 | 58.7% | CN¥466.26 Million | CN¥794.79 Million | CN¥328.53 Million | — |